• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据不同的参考方程进行肺量计解读和临床相关性评估。

Spirometric Interpretation and Clinical Relevance According to Different Reference Equations.

机构信息

Division of Respiratory and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.

出版信息

J Korean Med Sci. 2024 Jan 29;39(4):e20. doi: 10.3346/jkms.2024.39.e20.

DOI:10.3346/jkms.2024.39.e20
PMID:38288534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10825457/
Abstract

BACKGROUND

Global Lung Function Initiative (GLI)-2012 reference equation is currently suggested for interpretation of spirometry results and a new local reference equation has been developed in South Korea. However, lung function profiles according to the different reference equations and their clinical relevance have not been identified in chronic obstructive pulmonary disease (COPD) patients.

METHODS

Our cross-sectional study evaluated Choi's, Korean National Health and National Examination Survey (KNHANES)-VI, and GLI-2012 reference equations. We estimated the percentages of predictive forced expiratory volume in one second (FEV) and airflow limitation severity according to reference equations and analyzed their associations with patient reported outcomes (PROs): COPD assessment test (CAT) score, St. George's Respiratory Questionnaire for COPD patients (SGRQ-C) score, and six minute walk distance (6MWD).

RESULTS

In the eligible 2,180 COPD patients, lower predicted values of FEV and forced vital capacity (FVC) were found in GLI-2012 compared to Choi's and KNHANES-VI equations. GLI-2012 equation resulted in a lower proportion of patients being classified as FEV < 80% or FVC < 80% compared to the other equations. However, the Z-scores of FEV and FVC were similar between the KNHANES-VI and GLI-2012 equations. Three reference equations exhibited significant associations between FEV (%) and patient-reported outcomes (CAT score, SGRQ-C score, and 6MWD).

CONCLUSION

GLI-2012 reference equation may not accurately reflect FEV (%) in the Korean population, but the Z-score using GLI-2012 equation can be a viable option for assessing FEV and airflow limitation in COPD patients. Similar to the other two equations, the GLI-2012 equation demonstrated significant associations with PROs.

摘要

背景

全球肺功能倡议(GLI)-2012 参考方程目前被建议用于解释肺活量测定结果,并且已经在韩国开发了新的本地参考方程。然而,根据不同的参考方程,以及它们在慢性阻塞性肺疾病(COPD)患者中的临床相关性,尚未确定肺功能特征。

方法

我们的横断面研究评估了 Choi 氏、韩国国家健康和国家体检调查(KNHANES)-VI 和 GLI-2012 参考方程。我们根据参考方程估计了预测的一秒用力呼气量(FEV)和气流受限严重程度的百分比,并分析了它们与患者报告的结局(PRO)的关联:COPD 评估测试(CAT)评分、COPD 患者圣乔治呼吸问卷(SGRQ-C)评分和 6 分钟步行距离(6MWD)。

结果

在符合条件的 2180 名 COPD 患者中,与 Choi 氏和 KNHANES-VI 方程相比,GLI-2012 方程预测的 FEV 和用力肺活量(FVC)值较低。与其他方程相比,GLI-2012 方程导致较少的患者被归类为 FEV <80%或 FVC <80%。然而,FEV 和 FVC 的 Z 评分在 KNHANES-VI 和 GLI-2012 方程之间相似。三个参考方程均显示 FEV(%)与患者报告的结局(CAT 评分、SGRQ-C 评分和 6MWD)之间存在显著关联。

结论

GLI-2012 参考方程可能无法准确反映韩国人群的 FEV(%),但使用 GLI-2012 方程的 Z 评分可以成为评估 COPD 患者 FEV 和气流受限的可行选择。与其他两个方程一样,GLI-2012 方程与 PRO 具有显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/93fd48a65046/jkms-39-e20-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/660a0d8e67c9/jkms-39-e20-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/bc6f804c91f5/jkms-39-e20-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/93fd48a65046/jkms-39-e20-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/660a0d8e67c9/jkms-39-e20-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/bc6f804c91f5/jkms-39-e20-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15b/10825457/93fd48a65046/jkms-39-e20-g003.jpg

相似文献

1
Spirometric Interpretation and Clinical Relevance According to Different Reference Equations.根据不同的参考方程进行肺量计解读和临床相关性评估。
J Korean Med Sci. 2024 Jan 29;39(4):e20. doi: 10.3346/jkms.2024.39.e20.
2
Influences of Two FEV Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.两种 FEV 参考方程(GLI-2012 和 GIRH-2017)对 COPD 患者气流受限分类的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022.
3
Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD.全球肺功能倡议肺活量测定参考方程对东北亚慢性阻塞性肺疾病患者的意义
Chest. 2025 Feb;167(2):414-424. doi: 10.1016/j.chest.2024.08.048. Epub 2024 Sep 12.
4
Global Lung Function Initiative 2012 reference values for spirometry in South Italian children.全球肺功能倡议 2012 年南意大利儿童肺量计参考值。
Respir Med. 2017 Oct;131:11-17. doi: 10.1016/j.rmed.2017.07.061. Epub 2017 Aug 1.
5
Pulmonary function of healthy Korean children from three independent birth cohorts: Validation of the Global Lung Function Initiative 2012 equation.韩国三个独立出生队列中健康儿童的肺功能:全球肺功能倡议 2012 方程的验证。
Pediatr Pulmonol. 2021 Oct;56(10):3310-3320. doi: 10.1002/ppul.25622. Epub 2021 Aug 25.
6
Comparison of race-specific and race-neutral GLI spirometric reference equations with an Indian reference equation.种族特异性和种族中性 GLI 肺量计参考方程与印度参考方程的比较。
Respir Med. 2024 Oct;232:107764. doi: 10.1016/j.rmed.2024.107764. Epub 2024 Aug 10.
7
Which reference equation should we use for interpreting spirometry values for First Nations Australians? A cross-sectional study.我们应该使用哪个参考方程来解释澳大利亚原住民的肺活量值?一项横断面研究。
Med J Aust. 2024 Jun 3;220(10):523-529. doi: 10.5694/mja2.52306. Epub 2024 May 13.
8
Impact of switching to new spirometric reference equations on severity staging of airflow obstruction in COPD: a crosssectional observational study in primary care.改用新的肺量计参考方程对慢性阻塞性肺疾病气流阻塞严重程度分期的影响:一项初级保健中的横断面观察性研究
Prim Care Respir J. 2014 Mar;23(1):85-91. doi: 10.4104/pcrj.2014.00006.
9
Impacts of Different Spirometry Reference Equations and Diagnostic Criteria on the Frequency of Airway Obstruction in Adult People of North China.不同肺量计参考方程和诊断标准对华北地区成年人群气道阻塞频率的影响。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 27;15:651-659. doi: 10.2147/COPD.S232863. eCollection 2020.
10
Outcome-based Definition of the Lower Limit of Normal in Spirometry: A Study of 26,000 Young Adult Men.基于结果的肺量计正常下限定义:一项对 26000 名成年男性的研究。
Ann Am Thorac Soc. 2024 Sep;21(9):1261-1271. doi: 10.1513/AnnalsATS.202312-1027OC.

引用本文的文献

1
Serum Cytokeratin 18 and Fragment as Biomarkers for Severity and Prognosis in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.血清细胞角蛋白18及其片段作为慢性阻塞性肺疾病急性加重严重程度和预后的生物标志物
Lung. 2025 Aug 11;203(1):87. doi: 10.1007/s00408-025-00841-3.
2
The Development of Population-Specific Spirometric Reference Equations for Iraqi Adults.伊拉克成年人特定人群肺量计参考方程的制定。
Healthcare (Basel). 2025 May 26;13(11):1254. doi: 10.3390/healthcare13111254.
3
Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD.

本文引用的文献

1
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.肺功能测试解读中的种族和民族差异:美国胸科学会官方声明。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995. doi: 10.1164/rccm.202302-0310ST.
2
Rapid FEV/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population.快速 FEV/FVC 下降与一般人群中阻塞性肺疾病的发病率和死亡率有关。
J Korean Med Sci. 2023 Jan 2;38(1):e4. doi: 10.3346/jkms.2023.38.e4.
3
Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.
慢性阻塞性肺疾病(COPD)中肺功能测试的挑战与未来:迈向COPD的早期诊断
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):413-418. doi: 10.4046/trd.2025.0009. Epub 2025 Mar 25.
4
Risk Factors of FEV₁/FVC Decline in COPD Patients.慢性阻塞性肺疾病患者第一秒用力呼气容积/用力肺活量下降的危险因素。
J Korean Med Sci. 2025 Feb 17;40(6):e32. doi: 10.3346/jkms.2025.40.e32.
5
Management of Chronic Obstructive Pulmonary Disease in Vietnam during the COVID-19 Period: Current Situation and Challenges.越南在新冠疫情期间慢性阻塞性肺疾病的管理:现状与挑战
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):322-333. doi: 10.4046/trd.2024.0140. Epub 2025 Feb 7.
6
Heterogeneity of reduced FEV in early adulthood: A looking forward, looking backwards analysis.成年早期用力呼气量降低的异质性:前瞻性与回顾性分析
Respirology. 2025 Apr;30(4):326-334. doi: 10.1111/resp.14876. Epub 2025 Jan 12.
7
Pulmonary Function Tests: Easy Interpretation in Three Steps.肺功能测试:三步轻松解读
J Clin Med. 2024 Jun 22;13(13):3655. doi: 10.3390/jcm13133655.
真实世界慢性阻塞性肺疾病队列中快速 FEV1 下降的危险因素。
Respiration. 2022;101(12):1078-1087. doi: 10.1159/000525871. Epub 2022 Nov 4.
4
Reference equations for evaluation of spirometry function tests in South Asia, and among South Asians living in other countries.评价南亚人群及居住在其他国家的南亚人群肺功能测试中肺活量测定法的参考值方程。
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.02962-2021. Print 2022 Dec.
5
Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prevalence and Obesity-Related Comorbidity Incidence Stratified by Age from 2009 to 2019.《2021年韩国肥胖情况说明书:2009年至2019年按年龄分层的肥胖患病率和肥胖相关合并症发病率趋势》
J Obes Metab Syndr. 2022 Jun 30;31(2):169-177. doi: 10.7570/jomes22024.
6
Rapid FEV Decline and Lung Cancer Incidence in South Korea.韩国的快速 FEV 下降与肺癌发病率。
Chest. 2022 Aug;162(2):466-474. doi: 10.1016/j.chest.2022.03.018. Epub 2022 Mar 19.
7
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
8
Pulmonary function of healthy Korean children from three independent birth cohorts: Validation of the Global Lung Function Initiative 2012 equation.韩国三个独立出生队列中健康儿童的肺功能:全球肺功能倡议 2012 方程的验证。
Pediatr Pulmonol. 2021 Oct;56(10):3310-3320. doi: 10.1002/ppul.25622. Epub 2021 Aug 25.
9
Pulmonary function testing in COPD: looking beyond the curtain of FEV1.COPD 中的肺功能测试:超越 FEV1 的帷幕。
NPJ Prim Care Respir Med. 2021 May 7;31(1):23. doi: 10.1038/s41533-021-00236-w.
10
Health-related quality of life associates with change in FEV in COPD: results from the COSYCONET cohort.健康相关生活质量与 COPD 患者 FEV 的变化相关:来自 COSYCONET 队列的结果。
BMC Pulm Med. 2020 May 29;20(1):148. doi: 10.1186/s12890-020-1147-5.